Dan Aderka
9Patents
6h-index
11Co-inventors
56Inventor score
Filing activity: Aug 6, 1990 → Dec 16, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5512544A | Pharmaceutical compositions comprising an anticytokine | Human Necessities | 79 | Expired |
| US5359037A | Antibodies to TNF binding protein I | Human Necessities | 53 | Expired |
| US5695953A | DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production | Human Necessities | 30 | Expired |
| US5811261A | Expression of the recombinant tumor necrosis factor binding protein I (TBP-I) | Chemistry; Metallurgy | 19 | Expired |
| US6479632B1 | Tumor necrosis factor inhibitory protein and its purification | Human Necessities | 8 | Expired |
| US5981701A | Tumor necrosis factor inhibitory protein and its purification | Human Necessities | 7 | Expired |
| US6608044B1 | Inhibition of TNF activity | Human Necessities | 4 | Expired |
| US5462731A | Use of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomas | Human Necessities | 2 | Expired |
| US8138323B2 | Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.